Status:
NOT_YET_RECRUITING
Application of the sG8 Scale in Real-World Geriatric Oncology Patients
Lead Sponsor:
Sichuan Cancer Hospital and Research Institute
Conditions:
Solid Cancers
Geriatric Assessment
Eligibility:
All Genders
65+ years
Brief Summary
This study is a multicenter, prospective, observational study. The study included patients aged 65 and older with solid tumors requiring systemic anti-tumor therapy. All patients underwent screening u...
Eligibility Criteria
Inclusion
- Patients aged 65 years or older.
- Patients with confirmed malignant tumors based on definitive pathological data.
- Patients who are assessed by clinicians to have indications for systemic anti-tumor therapy.
- Patients with a survival time greater than 12 weeks.
Exclusion
- Patients who do not meet the above inclusion criteria or are considered unsuitable for this study by the investigator due to other circumstances.
- Patients who are unwilling to cooperate in completing the sG8 scale assessment.
- Patients who do not understand the content of this study or are unwilling to participate.
Key Trial Info
Start Date :
May 16 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 30 2026
Estimated Enrollment :
346 Patients enrolled
Trial Details
Trial ID
NCT06939764
Start Date
May 16 2025
End Date
April 30 2026
Last Update
April 23 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.